Transdermal rotigotine for the perioperative management of restless legs syndrome
<p>Abstract</p> <p>Background</p> <p>Immobilisation, blood loss, sleep deficiency, and (concomitant) medications during perioperative periods might lead to acute exacerbation of symptoms in patients with the restless legs syndrome (RLS). Continuous transdermal delivery...
Main Authors: | Högl Birgit, Oertel Wolfgang H, Schollmayer Erwin, Bauer Lars |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/12/106 |
Similar Items
-
Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch
by: Trenkwalder Claudia, et al.
Published: (2010-09-01) -
The use of rotigotine in the treatment of restless legs syndrome
by: Anna Serafini, et al.
Published: (2010-07-01) -
Effects of rotigotine on clinical symptoms, quality of life and sleep hygiene adequacy in hemodialysis-associated restless legs syndrome
by: Vicent Esteve, et al.
Published: (2018-01-01) -
BEHAVIORAL AND NEUROPHYSIOLOGICAL EFFECTS OF TRANSDERMAL ROTIGOTINE IN ATYPICAL PARKINSONISM
by: Davide v Moretti, et al.
Published: (2014-06-01) -
Leukoderma Induced by Rotigotine Patch, a Transdermal Dopamine Agonist
by: Ronan Talty, et al.
Published: (2022-08-01)